FTC poised to referee telemedicine

Share this article:

The Federal Trade Commission is poised to dive into medical advice, specifically telemedicine. Medpage Today reports that the regulator—which oversees an array of matters that include deceptive advertising, internet neutrality, monopolies and robocalls, among other topics—is being nudged into this part of the medical field because of the technology involved.

Telemedicine, however, is about more than a chat from home. The larger issue is that the medium gives providers an opportunity to practice medicine beyond state borders.

MedPage notes that courts have already said doctors can only telemedicate in states in which the professionals meet medical requirements and that states can bar out-of-state professionals from advising patients from afar.

The FTC could get into the mix if it deems the ban on between-state advice as anti-competitive.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.